MedTrace Logo

Khalifa Effectiveness Study

NCT01762358 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-01-07

No results posted yet for this study

Summary

The primary hypothesis is that Khalifa's therapy brings additional benefit compared to standard therapy (physiotherapy) for patients with a ruptured anterior cruciate ligament (ACL).

Conditions

  • Total Rupture of the Anterior Cruciate Ligament in the Knee

Interventions

OTHER

Khalifa's therapy

One hour of Khalifa's therapy which is specially applied pressure to the skin

OTHER

Physiotherapy

Twelve times standardized Physiotherapy

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Engelbert Wallenböck, MD · UKH Graz

  • Robert Pehn, MD · AKH Kirchdorf

  • Frank Schneider, MD · LKH Graz

  • Andreas Kastner, MD · AKH Linz

  • Andreas Sandner, MD · Med Uni Graz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2011-05-31
Completion
2011-10-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01762358 on ClinicalTrials.gov